Cutting-Edge Elispot Platform for Immune Response Analysis

Welcome to our Cutting-Edge Elispot Platform, where we empower your research by providing a versatile and sensitive method for the analysis of cytotoxic T lymphocytes (CTLs) and their immune responses. Our platform offers a wide range of capabilities to support various research needs:

Multiple CTL Stimulation Methods

We offer various methods for CTL stimulation, including the use of human or mouse peripheral blood mononuclear cells (PBMCs) or splenic immune cell isolation for in vitro specific antigen presentation. Additionally, we can analyze peripheral blood or splenic cells collected from immunocompetent mice after in vivo immunization. We also specialize in CTL detection within tumor-infiltrating lymphocytes (TILs).

CTL Activation via Specific MHC Antigen Presentation

Our platform leverages the specific MHC antigen presentation pathway for CTL activation. This ensures that CTL activation is dependent on the presence of the appropriate MHC molecules, avoiding activation in cases of MHC mismatch.

Quantitative/Qualitative Analysis of CTL Production

We provide the capability for both quantitative and qualitative analysis of CTL production levels. This allows for a comprehensive assessment of the quantity and quality of CTL responses in your experimental systems.

High Sensitivity Detection

Our Elispot platform is known for its high sensitivity, enabling the detection of even low levels of CTL responses. This ensures that you can accurately measure and analyze CTL activity in various biological samples.

Applications in Clinical Cancer Vaccine Research

Our platform is ideally suited for the analysis of clinical patient samples, as well as mouse peripheral blood or TIL cells to quantify CTL cell populations. This application is particularly valuable in cancer vaccine research, where understanding and monitoring CTL responses are critical.

Support for In Vitro Studies of Tumor Vaccines and Immunomodulatory Drugs

Our Elispot platform is a valuable tool for in vitro studies of tumor vaccines and other immunomodulatory drugs that rely on specific immune activation pathways. It provides insights into the effectiveness of these therapies and aids in their development.

If you have any questions or are interested in utilizing our platform for your research, please don't hesitate to contact us. We look forward to helping you advance your studies in immunology and cancer research through our state-of-the-art Elispot technology.

• Quantitative / qualitative analysis possible

• Only a small sample of PBMC cells is required

• High detection sensitivity

• CTL cells in tumor vaccine clinical patient samples, mouse peripheral blood or TIL cells .

Case study 1： ELISpot detection of tumor vaccine activation ability : in vitro study

Case study 2： ELISpot detection of tumor vaccine activation ability : in vivo study in immune-competent mice